Lately, it was suggested that increased incorporation of P-S396-tau, P-T181-tau, and Aβ1–42 in neurally derived blood exosomes predict the occurrence of AD up to 10 years before clinical onset (Fiandaca et al., 2015). The gene discussed is MAPT; the disease is Alzheimer disease.